MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death

Nature Cell Biology

Volumn 19, Issue 10, 2017, Pages 1237-1247

  Dondelinger, Yves ^a,b   Delanghe, Tom ^a,b   Rojas Rivera, Diego ^a,b   Priem, Dario ^a,b   Delvaeye, Tinneke ^a,b   Bruggeman, Inge ^a,b   Van Herreweghe, Franky ^a,b   Vandenabeele, Peter ^a,b   Bertrand, Mathieu J M ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; MAP-KINASE-ACTIVATED KINASE 2; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; RIPK1 PROTEIN, MOUSE; SERINE; SIGNAL PEPTIDE; TNFRSF1A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; EMBRYO; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; IN VITRO STUDY; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; SHOCK; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; FIBROBLAST; GENETICS; METABOLISM; NECROSIS; PATHOLOGY; PHOSPHORYLATION; TIME FACTOR;

ANIMALS; APOPTOSIS; CELL LINE; CYTOSOL; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NECROSIS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SERINE; SHOCK; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85031923256     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3608     Document Type: Article

References (50)

1. Croft, M., Benedict, C. A. & Ware, C. F. Clinical targeting of the TNF and TNFR superfamilies. Nat. Rev. Drug Discov. 12, 147-168 (2013)
2. Berger, S. B. et al. Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J. Immunol. 192, 5476-5480 (2014)
3. Rickard, J. A. et al. TNFR1-dependent cell death drives inflammation in Sharpindeficient mice. eLife 3, e03464 (2014)
4. Vlantis, K. et al. NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-B-dependent and-independent functions. Immunity 44, 553-567 (2016)
5. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311-320 (2015)
6. Ting, A. T. & Bertrand, M. J. More to life than NF-B in TNFR1 signaling. Trends Immunol. 37, 535-545 (2016)
7. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-induced apoptosis by NF-B. Science 274, 787-789 (1996)
8. Liu, Z. G., Hsu, H., Goeddel, D. V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-B activation prevents cell death. Cell 87, 565-576 (1996)
9. Peltzer, N., Darding, M. & Walczak, H. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol. 26, 445-461 (2016)
10. Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700 (2008)
11. Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844 (2009)
12. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011)
13. Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNF-mediated NF-B activation. Proc. Natl Acad. Sci. USA 105, 11778-11783 (2008)
14. Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor (TNF)-induced NF-B activation. J. Biol. Chem. 283, 24295-24299 (2008)
15. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNF requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245-257 (2006)
16. Kanayama, A. et al. TAB2 and TAB3 activate the NF-B pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004)
17. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001)
18. Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-B activation. Cell 136, 1098-1109 (2009)
19. Draber, P. et al. LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell Rep. 13, 2258-2272 (2015)
20. Wang, L., Du, F. & Wang, X. TNF-induces two distinct caspase-8 activation pathways. Cell 133, 693-703 (2008)
21. Wilson, N. S., Dixit, V. & Ashkenazi, A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355 (2009)
22. Dondelinger, Y. et al. NF-B-independent role of IKK /IKK in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol. Cell 60, 63-76 (2015)
23. Dondelinger, Y. et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinasedependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ. 20, 1381-1392 (2013)
24. O'Donnell, M. A., Legarda-Addison, D., Skountzos, P., Yeh, W. C. & Ting, A. T. Ubiquitination of RIP1 regulates an NF-B-independent cell-death switch in TNF signaling. Curr. Biol. 17, 418-424 (2007)
25. O'Donnell, M. A., Hase, H., Legarda, D. & Ting, A. T. NEMO inhibits programmed necrosis in an NFB-independent manner by restraining RIP1. PLoS ONE 7, e41238 (2012)
26. Petersen, S. L. et al. Autocrine TNF signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445-456 (2007)
27. Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123 (2009)
28. He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-. Cell 137, 1100-1111 (2009)
29. Cargnello, M. & Roux, P. P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50-83 (2011)
30. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190 (2003)
31. Zhang, Y. et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat. Commun. 8, 14329 (2017)
32. de Almagro, M. C. et al. Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death. Cell Death Differ. 24, 26-37 (2016)
33. Boutaffala, L. et al. NIK promotes tissue destruction independently of the alternative NF-B pathway through TNFR1/RIP1-induced apoptosis. Cell Death Differ. 22, 2020-2033 (2015)
34. Vince, J. E. et al. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNF. J. Cell Biol. 182, 171-184 (2008)
35. Duprez, L. et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908-918 (2011)
36. Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565-1576 (2016)
37. Takahashi, N. et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437 (2012)
38. Degterev, A., Maki, J. L. & Yuan, J. Activity and specificity of necrostatin-1, smallmolecule inhibitor of RIP1 kinase. Cell Death Differ. 20, 366 (2013)
39. Legarda-Addison, D., Hase, H., O'Donnell, M. A. & Ting, A. T. NEMO/IKK regulates an early NF-B-independent cell-death checkpoint during TNF signaling. Cell Death Differ. 16, 1279-1288 (2009)
40. Koppe, C. et al. IB kinase = control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64, 1217-1231 (2016)
41. Lalaoui, N. et al. Targeting p38 or MK2 enhances the anti-leukemic activity of Smacmimetics. Cancer Cell 30, 499-500 (2016)
42. Ben-Levy, R., Hooper, S., Wilson, R., Paterson, H. F. & Marshall, C. J. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr. Biol. 8, 1049-1057 (1998)
43. Engel, K., Kotlyarov, A. & Gaestel, M. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 17, 3363-3371 (1998)
44. Vandendriessche, B. et al. MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock. BMC Physiol. 14, 5 (2014)
45. Jaco, I. et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol. Cell 66, 698-710 (2017)
46. Silke, J., Rickard, J. A. & Gerlic, M. The diverse role of RIP kinases in necroptosis and inflammation. Nat. Immunol. 16, 689-697 (2015)
47. Menon, M. et al. p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signaling in inflammation and infection. Nat. Cell Biol. 19, 1248-1259 (2017)
48. Dejardin, E. et al. The lymphotoxin-receptor induces different patterns of gene expression via two NF-B pathways. Immunity 17, 525-535 (2002)
49. Ronkina, N. et al. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27, 170-181 (2007)
50. Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095 (2005).